House Status:
Senate Status:
Senate Status:
SB 236
Short Title
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice. (more)
Bill Versions
FN: Fiscal Note
| Version | Documents | FN |
|---|---|---|
| As introduced |
|
|
Bill History
JPN: Journal Page Number
| Date | Chamber | Status | JPN |
|---|---|---|---|
| Tue, Apr 30, 2024 | Senate | Died in Committee | |
| Mon, Feb 13, 2023 | Senate | Referred to Committee on Financial Institutions and Insurance | 93 |
| Fri, Feb 10, 2023 | Senate | Introduced | 91 |
2024. Powered by KLISS. Rendered: 2024-10-05T20:52:00. Head Rev No: 798416(I)
